Victory Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
Victory Capital Management's ALT Position: Q3 2026 in Review
Victory Capital Management reduced its Altimmune (ALT) stake by 1% in Q3 2026, selling an estimated $654 and leaving 21,005 shares worth $60.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2417.
Victory Capital Management first reported a position in ALT in Q3 2019 and has held it in 7 quarters since. The position peaked at $64.5K in Q2 2026. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- Victory Capital Management held 21,005 shares of Altimmune worth $60.1K as of Q3 2026.
- Victory Capital Management sold 213 Altimmune shares in Q3 2026, an estimated $654.
- Altimmune made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2417 holding.
- Victory Capital Management first reported a position in Altimmune in Q3 2019 and has held it in 7 quarters since.
- Victory Capital Management's Altimmune position peaked at $64.5K in Q2 2026.
- 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.